(1)SK Bioscience SAMSUNGGBIOLOGICS
image text translation
(2)Bio industry “Even with a little experience, annual salary of 100 million won”
(3)Lack of supply rather than serious demand for medical schools
(4)It is a price ceiling for intensifying labor competition among industries.
(5)The bio industry has surpassed 100 million annual salary on average.
(6)
(7)Investment scale Investment period 100 million won
(8)Key Investments Status and Planning
(9)Construction of Songdo Plant 4 completed in June 23
(10)Samsung Biologics Vaccine·Bio Incheon Songdo
(11)Additional Construction of Songdo 567 Plant 8
(12)· Expansion of Songdo Plant 3 and establishment of a research center Establishment of Songdo Plant 4 and other investments
(13)Celltrion Lotte Biologics SK Bioscience Daewoong Pharmaceutical Incheon Songdo
(14)Establishment of biopharmaceutical production plant
(15)Incheon Songdo Songdo Songdo Global Vaccine Bio Research and Development Production Center Expansion of Andong and Andong Vaccine Plants in Gyeongbuk
(16)Hwaseong Fortress in Gyeonggi Province
(17)Establishment of biopharmaceutical GMP plant, etc.
(18)Osong, North Chungcheong Province
(19)Expansion of Ochang Biopharmaceutical Factory in Chungcheongbuk-do and New Construction of Hwasun MRNA Vaccine Production Facility in Jeollanam-do
(20)GC Green Cross Vaccine and Bio
(21)·Vaccine Prestige for Osong Plant 3
(22)Vaccine and Bio: Osong, Chungcheongbuk-do
(23)Expansion of Osong 2nd Plant and Establishment of 4th Plant BioVaccine Gangwon Chuncheon Vaccine Fluid and Completed Production Plant Construction Vaccine Biologics
(24)UBioLogics LG Chem
(25)Construction of a mixed vaccine production line based on Osong Refinery, Chungcheongbuk-do Construction of Incheon Songdo Badge Resin Production Plant and Equipment
(26)Resin Yeosu, Baeji Songdo, Yeosu, Jeollanam-do
(27)Enzichem Life Sciences Korea Vaccine Expansion of Osong mRNA and DNA Plant in North Chungcheong Province
(28)Vaccine Korea Chorus Vaccine, Bio Gangwon Chuncheon Vaccine, and Bio Production Facility Investment BioApp in Ansan, Gyeonggi Province
(29)Korea-U.S. Department of Precision and Chemicals expanded production facilities for raw materials in Siheung, Gyeonggi Province, and expanded production facilities and equipment for STPAM vaccine in Ansan, Gyeonggi Province.
(30)Incheon Namdong-gu and Equipment Manufacturing Plant and Production Facility Expansion
(31)Building GMP facilities for Osong mRNA manufacturing in Chungcheongbuk-do Korea BMI
(32)Construction of cleaning agent plant for refining process in Dangjin, Chungcheongnam-do
(33)Establishment of production equipment and facilities such as vaccine, bio-Gyeonggi Pyeongtaek, mRNA vaccine, etc.
the bio-industry